Home
  • E-mailSverre.Sandberg@uib.no
  • Phone+47 55 58 67 06
  • Visitor Address
    Alrek helseklynge, blokk D, Årstadveien 17
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2019). Variation in the achievement of HbA1c, blood pressure and LDL cholesterol targets in type 2 diabetes in general practice and characteristics associated with risk factor control. Diabetic Medicine. 1-11.
  • Show author(s) (2019). The importance of the Biological Variation Data Critical Appraisal Checklist when designing experimental studies on biological variation. Comparison of two papers reporting biological variation results for S100-β and neuron-specific enolase proteins. Biochimica Clinica. 59-66.
  • Show author(s) (2019). Setting clinical performance specifications to develop and evaluate biomarkers for clinical use. Annals of Clinical Biochemistry. 1-9.
  • Show author(s) (2019). Self-efficacy and self-management strategies in acute intermittent porphyria. BMC Health Services Research.
  • Show author(s) (2019). Pre-analytical practices for routine coagulation tests in European laboratories. A collaborative study from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM). Clinical Chemistry and Laboratory Medicine. 1511-1521.
  • Show author(s) (2019). Porphyria cutanea tarda increases risk of hepatocellular carcinoma and premature death: A nationwide cohort study. Orphanet Journal of Rare Diseases. 1-10.
  • Show author(s) (2019). International Porphyria Molecular Diagnostic Collaborative: an evidence-based database of verified pathogenic and benign variants for the porphyrias. Genetics in Medicine. 1-9.
  • Show author(s) (2019). Factors associated with glycaemic control in adults with Type 1 diabetes: a registry-based analysis including 7601 individuals from 34 centres in Norway. Diabetic Medicine. 1-10.
  • Show author(s) (2019). Exploring the relationship between coronary heart disease and type 2 diabetes: a cross-sectional study of secondary prevention among diabetes patients. British Journal of General Practice Open. 11 pages.
  • Show author(s) (2019). European Biological Variation Study (EuBIVAS): Within- and between-subject biological variation data for 15 frequently measured proteins. Clinical Chemistry. 1031-1041.
  • Show author(s) (2019). Ethnic and gender differences in the management of type 2 diabetes: a cross-sectional study from Norwegian general practice. BMC Health Services Research. 1-11.
  • Show author(s) (2019). A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria. Molecular Therapy.
  • Show author(s) (2019). A Bayesian Approach to Biological Variation Analysis. Clinical Chemistry. 995-1005.
  • Show author(s) (2018). Within-subject biological variation of activated partial thromboplastin time, prothrombin time, fibrinogen, factor VIII and von Willebrand factor in pregnant women. Clinical Chemistry and Laboratory Medicine. 1-12.
  • Show author(s) (2018). Within-subject and between-subject biological variation estimates of 21 hematological parameters in 30 healthy subjects. Clinical Chemistry and Laboratory Medicine. 1309-1318.
  • Show author(s) (2018). Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes ? A feasibility study. PLOS ONE. 1-13.
  • Show author(s) (2018). Quality control of Norwegian pharmacy HbA1c testing: a modest beginning. Journal of Diabetes Science and Technology. 753-761.
  • Show author(s) (2018). Practical guide for identifying unmet clinical needs for biomarkers. Electronic Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (eJIFCC). 129-137.
  • Show author(s) (2018). Hjemmetjenesten driver omfattende laboratorievirksomhet. Sykepleien Forskning. 1-15.
  • Show author(s) (2018). Harmonization activities of Noklus - A quality improvement organization for point-of-care laboratory examinations. Clinical Chemistry and Laboratory Medicine. 106-114.
  • Show author(s) (2017). Warfarin monitoring in nursing homes assessed by case histories. Do recommendations and electronic alerts affect judgements? Scandinavian Journal of Primary Health Care. 299-306.
  • Show author(s) (2017). The biological variation data critical appraisal checklist: A standard for evaluating studies on biological variation. Clinical Chemistry. 501-514.
  • Show author(s) (2017). The EuBIVAS project: within- and between-subject biological variation data for serum creatinine using enzymatic and alkaline picrate methods and implications for monitoring. Clinical Chemistry. 1527-1536.
  • Show author(s) (2017). Strategies to define performance specifications in laboratory medicine: 3 years on from the Milan Strategic Conference. Clinical Chemistry and Laboratory Medicine. 1849-1856.
  • Show author(s) (2017). A pragmatic approach to sample acceptance and rejection. Clinical Biochemistry. 605-611.
  • Show author(s) (2016). Sample collections from healthy volunteers for biological variation estimates' update: A new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory Medicine. Clinical Chemistry and Laboratory Medicine. 1599-1608.
  • Show author(s) (2016). Is D-dimer used according to clinical algorithms in the diagnostic work-up of patients with suspicion of venous thromboembolism? A study in six European countries. Thrombosis Research. 1-7.
  • Show author(s) (2016). Biological variation: The effect of different distributions on estimated within-person variation and reference change values. Clinical Chemistry. 725-736.
  • Show author(s) (2015). Setting analytical performance specifications based on outcome studies - Is it possible? Clinical Chemistry and Laboratory Medicine. 841-848.
  • Show author(s) (2015). Proposal for the modification of the conventional model for establishing performance specifications. Clinical Chemistry and Laboratory Medicine. 925-937.
  • Show author(s) (2015). Point-of-care urine albumin in general practice offices: Effect of participation in an external quality assurance scheme. Clinical Chemistry and Laboratory Medicine. 45-51.
  • Show author(s) (2015). Egenkontroll av warfarinbehandling. Tidsskrift for Den norske legeforening. 849-853.
  • Show author(s) (2015). Benchmarking by HbA1c in a national diabetes quality register - does measurement bias matter? Clinical Chemistry and Laboratory Medicine. 1433-1439.
  • Show author(s) (2015). Analytical performance specifications based on how clinicians use laboratory tests. Experiences from a post-analytical external quality assessment programme. Clinical Chemistry and Laboratory Medicine. 857-862.
  • Show author(s) (2015). A checklist for critical appraisal of studies of biological variation. Clinical Chemistry and Laboratory Medicine. 879-885.
  • Show author(s) (2014). Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls. Clinical Chemistry. 838-847.
  • Show author(s) (2014). The influence of coagulation factors on the in-treatment biological variation of international normalized ratio for patients on warfarin. Scandinavian Journal of Clinical and Laboratory Investigation. 470-476.
  • Show author(s) (2014). Porfyrisykdommer i Norge. Tidsskrift for Den norske legeforening. 831-835.
  • Show author(s) (2014). Nursing home patients with diabetes: Prevalence, drug treatment and glycemic control. Diabetes Research and Clinical Practice. 102-109.
  • Show author(s) (2014). How to achieve harmonisation of laboratory testing -The complete picture. Clinica Chimica Acta. 8-14.
  • Show author(s) (2014). From biomarkers to medical tests: The changing landscape of test evaluation. Clinica Chimica Acta. 49-57.
  • Show author(s) (2014). From biomarkers to medical tests: The changing landscape of test evaluation. Clinica Chimica Acta. 49-57.
  • Show author(s) (2014). Albumin adsorption onto surfaces of urine collection and analysis containers. Clinica Chimica Acta. 40-45.
  • Show author(s) (2013). The incidence of inherited porphyrias in Europe. The Journal of Inherited Metabolic Disease (JIMD). 849-857.
  • Show author(s) (2013). The Norwegian Diabetes Register for Adults –an overview of the first years. Norsk Epidemiologi. 29-34.
  • Show author(s) (2013). Preanalytical quality improvement: in quality we trust. Clinical Chemistry and Laboratory Medicine. 229-241.
  • Show author(s) (2013). Heterogeneity in the handling of vitamin-K-antagonists and of INR: the example of Quercy-Rouergue. Annales de Biologie Clinique. 707-716.
  • Show author(s) (2013). External quality assessment of point-of-care methods: model for combined assessment of method bias and single-participant performance by the use of native patient samples and noncommutable control materials. Clinical Chemistry. 363-371.
  • Show author(s) (2013). Diagnosing Diabetes Mellitus: Performance of Hemoglobin A(1c) Point-of-Care Instruments in General Practice Offices. Clinical Chemistry. 1790-1801.
  • Show author(s) (2013). Conformational stability and activity analysis of two hydroxymethylbilane synthase mutants, K132N and V215E, with different phenotypic association with acute intermittent porphyria. Bioscience Reports. 617-U203.
  • Show author(s) (2013). Behandlingen av type 1-diabetes i spesialisthelsetjenesten – data fra Norsk diabetesregister for voksne. Tidsskrift for Den norske legeforening. 2257-2261.
  • Show author(s) (2013). A systematic review of data on biological variation for alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase. Clinical Chemistry and Laboratory Medicine. 1997-2007.
  • Show author(s) (2012). Regional differences in sales of glucometer strips and antidiabetics. Tidsskrift for Den norske legeforening. 1453-1456.
  • Show author(s) (2012). Preanalytical quality improvement: in quality we trust. Clinical Chemistry and Laboratory Medicine.
  • Show author(s) (2012). Interpretation and management of INR results: A case history based survey in 13 countries. Thrombosis Research. 309-315.
  • Show author(s) (2012). Increased yet iron-restricted erythropoiesis in postpartum mothers. Annals of Hematology. 1435-1441.
  • Show author(s) (2012). How do laboratory specialists advise clinicians concerning the use and interpretation of renal tests? Scandinavian Journal of Clinical and Laboratory Investigation. 143-151.
  • Show author(s) (2012). External quality assessment of point-of-care International Normalized Ratio (INR) testing in Europe. Clinical Chemistry and Laboratory Medicine. 81-88.
  • Show author(s) (2012). Establishing a network of specialist Porphyria centres - effects on diagnostic activities and services. Orphanet Journal of Rare Diseases. 9 pages.
  • Show author(s) (2012). Effect of coagulation factors on discrepancies in International Normalized Ratio results between instruments. Clinical Chemistry and Laboratory Medicine. 1611-1620.
  • Show author(s) (2012). Confidence intervals and power calculations for within-person biological variation: effect of analytical imprecision, number of replicates, number of samples, and number of individuals. Clinical Chemistry. 1306-1313.
  • Show author(s) (2012). A model for calculating the within-subject biological variation and likelihood ratios for analytes with a time-dependent change in concentrations; exemplified with the use of D-dimer in suspected venous thromboembolism in healthy pregnant women. Annals of Clinical Biochemistry. 561-569.
  • Show author(s) (2011). Within-subject biological variation of glucose and HbA(1c) in healthy persons and in type 1 diabetes patients. Clinical Chemistry and Laboratory Medicine. 1501-1507.
  • Show author(s) (2011). Standardisert hemoglobin A1C til diagnostisk bruk? Tidsskrift for Den norske legeforening. 565-6.
  • Show author(s) (2011). Quality assurance of laboratory work and clinical use of laboratory tests in general practice in Norway: A survey. Scandinavian Journal of Primary Health Care. 171-175.
  • Show author(s) (2011). Preanalytical quality improvement: from dream to reality. Clinical Chemistry and Laboratory Medicine. 1113-1126.
  • Show author(s) (2011). Laboratory investigation and follow-up of chronic kidney disease stage 3 in primary care. Clinica Chimica Acta. 1138-1142.
  • Show author(s) (2011). Excess risk of adverse pregnancy outcomes in women with porphyria: a population-based cohort study. The Journal of Inherited Metabolic Disease (JIMD). 217-223.
  • Show author(s) (2011). European specialist porphyria laboratories: diagnostic strategies, analytical quality, clinical interpretation, and reporting as assessed by an external quality assurance program. Clinical Chemistry. 1514-1523.
  • Show author(s) (2011). Effect of ambient temperature on analytical performance of self-monitoring blood glucose systems. Diabetes Technology & Therapeutics. 883-892.
  • Show author(s) (2011). Do new concepts for deriving permissible limits for analytical imprecision and bias have any advantages over existing consensus? Clinical Chemistry and Laboratory Medicine. 637-640.
  • Show author(s) (2010). Usefulness of factor V Leiden mutation testing in clinical practice. European Journal of Human Genetics. 862-866.
  • Show author(s) (2010). Quality assessment of patients’ self-monitoring of blood glucose in community pharmacies. Pharmacy Practice. 62-69.
  • Show author(s) (2010). Porfyri: Symptomer - diagnostisering - behandling. Bioingeniøren. 6-9.
  • Show author(s) (2010). Implementation of a method for glucose measurements in community pharmacies. International Journal of Pharmacy Practice (IJPP). 13-19.
  • Show author(s) (2010). Discrepancies in International Normalized Ratio Results between Instruments: A Model to Split the Variation into Subcomponents. Clinical Chemistry. 1618-1626.
  • Show author(s) (2010). Diagnosing microalbuminuria and consequences for the drug treatment of patients with type 2 diabetes: A European survey in primary care. Diabetes Research and Clinical Practice. 103-109.
  • Show author(s) (2009). Quality of Care for Patients With Type 2 Diabetes in Primary Care in Norway Is Improving Results of cross-sectional surveys of 33 general practices in 1995 and 2005. Diabetes Care. 81-83.
  • Show author(s) (2009). Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials. Thrombosis and Haemostasis. 593-600.
  • Show author(s) (2009). How to deal with semi-quantitative tests? Application of an ordinal scale model to measurements of urine glucose. Scandinavian Journal of Clinical and Laboratory Investigation. 662-U18.
  • Show author(s) (2009). Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies. Clinical Chemistry. 795-803.
  • Show author(s) (2009). Familial and sporadic porphyria cutanea tarda: Characterization and diagnostic strategies. Clinical Chemistry. 795-803.
  • Show author(s) (2008). Riktigere bruk av laboratorietjenester – økonomiske aspekter. Tidsskrift for Den norske legeforening. 814-817.
  • Show author(s) (2008). Riktigere bruk av laboratorietjenester – medisinske aspekter. Tidsskrift for Den norske legeforening. 810-813.
  • Show author(s) (2008). Postanalytical external quality assessment of urine albumin in primary health care: An international survey. Clinical Chemistry. 1630-1636.
  • Show author(s) (2008). How to deal with dichotomous tests? Application of a rankit ordinal scale model with examples from the Nordic ordinal scale project on screening tests. Scandinavian Journal of Clinical and Laboratory Investigation. 298-311.
  • Show author(s) (2008). Diabetes care in Norwegian pharmacies: a descriptive study. Pharmacy World & Science (PWS). 191-198.
  • Show author(s) (2008). 'Likelihood-ratio' and 'odds' applied to monitoring of patients as a supplement to 'reference change value' (RCV). Clinical Chemistry and Laboratory Medicine. 157-164.
  • Show author(s) (2006). Results and feasibility of an external quality assessment scheme for self-monitoring of blood glucose. Clinical Chemistry. 1311-1317.
  • Show author(s) (2006). Proficiency testing in analytical chemistry, microbiology and laboratory medicine - working group discussions on current status, problems and future directions. Accreditation and Quality Assurance. 446-450.
  • Show author(s) (2006). Postanalytical external quality assessment of warfarin monitoring in primary healthcare. Clinical Chemistry. 1871-1878.
  • Show author(s) (2006). Postanalytical external quality assessment of warfarin monitoring in primary healthcare. Clinical Chemistry.
  • Show author(s) (2006). External quality assessment of prothrombin time: The split-sample model compared with external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation. 337-349.
  • Show author(s) (2006). Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria. Clinical Chemistry. 650-656.
  • Show author(s) (2006). Estimation and Application of Biological Variation of Urinary δ-Aminolevulinic Acid and Porphobilinogen in Healthy Individuals and in Patients with Acute Intermittent Porphyria. Clinical Chemistry. 650-656.
  • Show author(s) (2005). Porphyrias, a challenge for diagnostic assessment and treatment. Clinical Laboratory International. 6-8.
  • Show author(s) (2005). Between-lot variation in external quality assessment of glucose: Clinical importance and effect on participant performance evaluation. Clinical Chemistry. 1632-1636.
  • Show author(s) (2004). Urine analysis and decision-making on cystitis in general practice. Scandinavian Journal of Clinical and Laboratory Investigation. 729-736.
  • Show author(s) (2004). Prostrate-specific antigen and prostate cancer: General practitioners' and urologists' use of evidence-based information. Tidsskrift for Den norske legeforening. 2893-2895.
  • Show author(s) (2004). Evidence-based guidelines in laboratory medicine: Principles and methods. Clinical Chemistry. 806-818.
  • Show author(s) (2004). Basic model and preliminary results on a Nordfond project on measurements reported on an ordinal scale. Klinisk Biokemi i Norden. 21-26.
  • Show author(s) (2004). A multicentre study of reference intervals for haemoglobin, basic blood cell counts and erythrocyte indices in the adult population of the Nordic countries. Scandinavian Journal of Clinical and Laboratory Investigation. 385-398.
  • Show author(s) (2003). Human reticulocytes isolated from peripheral blood: maturation time and hemoglobin synthesis. Laboratory Hematology. 198-206.
  • Show author(s) (2003). Health technology assessment and implications for clinical practice: The case of prostate cancer screening. Scandinavian Journal of Clinical and Laboratory Investigation. 331-338.
  • Show author(s) (2003). Haplotype analysis of Norwegian and Swedish patients with acute intermittent porphyria (AIP): Extreme haplotype heterogeneity for the mutation R116W. Disease Markers. 41-46.
  • Show author(s) (2003). Evaluering av nye laboratorieanalyser. Tidsskrift for Den norske legeforening. 337-339.
  • Show author(s) (2003). Evaluation of new laboratory tests. Tidsskrift for Den norske legeforening. 377-379.
  • Show author(s) (2003). Er GUM skadelig - eller blot overflødig? Klinisk Biokemi i Norden. 27-32.
  • Show author(s) (2002). Instruments for self-monitoring of blood-glucose: comparison of testing quality achieved by patients and a technician. Clinical Chemistry. 994-1003.
  • Show author(s) (2001). Quality of rapid tests for determination of infectious mononucleosis. Tidsskrift for Den norske legeforening. 1793-1797.
  • Show author(s) (2001). Patient-derived quality specifications for instruments used in self-monitoring of blood glucose. Clinical Chemistry. 67-73.
  • Show author(s) (2001). Models for combining random and systematic errors, assumptions and consequences for different models. Clinical Chemistry and Laboratory Medicine. 589-595.
  • Show author(s) (2001). Interpretation of hemaglobin A(1c)(HbA(1c)) values among diabetic patients: implications for quality specifications for HbA(1c). Clinical Chemistry. 1212-1217.
  • Show author(s) (2001). Influence of index of individuality on false positives in repeated sampling from healthy individuals. Clinical Chemistry and Laboratory Medicine. 160-165.
  • Show author(s) (2001). External quality assessment of general practice laboratories: organizational issues and interpretation of feedback reports. Scandinavian Journal of Clinical and Laboratory Investigation. 103-110.
  • Show author(s) (2001). Analyse av protrombintid i primærhelsetjenesten. Tidsskrift for Den norske legeforening. 3435-3436.
  • Show author(s) (2001). Akutt intermitterende porfyri er en vanskelig diagnose - spesielt hos barn. Tidsskrift for Den norske legeforening. 2822-2825.
  • Show author(s) (2000). Use and interpretation og HbA1c-testing in general practice. Implications for quality of care. Scandinavian Journal of Clinical and Laboratory Investigation. 349-356.
  • Show author(s) (2000). Use and interpretation og HbA1c-testing in general practice. Implications for quality of care. Scandinavian Journal of Clinical and Laboratory Investigation. 349-356.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av sår hals. Tidsskrift for Den norske legeforening. 1754-1760.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av sår hals. Läkartidningen. 4437-4448.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av sår hals. Läkartidningen. 1754-1760.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av sår hals. Tidsskrift for Den norske legeforening. 1754-1760.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av akutte vannlatingsplager hos kvinner. Tidsskrift for Den norske legeforening. 1748-1753.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av akutte vannlatingsplager hos kvinner. Tidsskrift for Den norske legeforening. 1748-1753.
  • Show author(s) (2000). Porphyrins and Porphyrias. Review and special articles from the Nordic countries. (Spesialnummer). Scandinavian Journal of Clinical and Laboratory Investigation. 508-648.
  • Show author(s) (2000). Porphyrins and Porphyrias. Review and special articles from the Nordic countries. (Spesialnummer). Scandinavian Journal of Clinical and Laboratory Investigation. 508-648.
  • Show author(s) (2000). Nodelling an estimation of measurement error. Statistics in Medicine. 146.
  • Show author(s) (2000). Nivået på dokumentasjonen og styrken på anbefalingene i kliniske retningslinjer. Tidsskrift for Den norske legeforening. 1791-1795.
  • Show author(s) (2000). Nivået på dokumentasjonen og styrken på anbefalingene i kliniske retningslinjer. Tidsskrift for Den norske legeforening. 1791-1795.
  • Show author(s) (2000). Kan laboratoriesvaret få konsekvenser for pasienten? Tidsskrift for Den norske legeforening. 2241.
  • Show author(s) (2000). Kan laboratoriesvaret få konsekvenser for pasienten? Tidsskrift for Den norske legeforening. 2241 pages.
  • Show author(s) (2000). Foster med hydrops hos kvinne fra Vietnam. Tidsskrift for Den norske legeforening. 1878-1881.
  • Show author(s) (2000). Foster med hydrops hos kvinne fra Vietnam. Tidsskrift for Den norske legeforening. 1878-1881.
  • Show author(s) (2000). Automated counting of white and red blood cells in the cerebrospinal fluid. Clinical and Laboratory Haematology. 203-210.
  • Show author(s) (2000). Automated counting of white and red blood cells in the cerebrospinal fluid. Clinical and Laboratory Haematology. 203-210.
  • Show author(s) (2000). A model for setting analytical quality specifications and design of control for measurements on the ordinal scale. Clinical Chemistry and Laboratory Medicine. 545-551.
  • Show author(s) (2000). A model for setting analytical quality specifications and design of control for measurements on the ordinal scale. Clinical Chemistry and Laboratory Medicine. 545-551.
  • Show author(s) (1999). The index of individuality is often a misinterpreted quantity characteristic. Clinical Chemistry and Laboratory Medicine. 655-661.
  • Show author(s) (1999). Skandinavisk utprøving av laboratorieutstyr for primærhelsetjenesten. Etablering av SKUP og igangsetting av de første evalueringene. Klinisk Biokemi i Norden. 56-60.
  • Show author(s) (1999). Quality specifications based upon objective analyses based upon clinical needs. Scandinavian Journal of Clinical and Laboratory Investigation.
  • Show author(s) (1999). Oppslagsbok i laboratoriemedisin. Tidsskrift for Den norske legeforening.
  • Show author(s) (1999). Measurement error and laboratory medicine. Statistics in Medicine.
  • Show author(s) (1999). External quality assurance of test requesting and test interpretations in general practice. A method for developing quality goals from clinicians' opinion and to implement guidelines. Labquality News. 13-14.
  • Show author(s) (1999). External quality assurance of test requesting and test interpretation. Accreditation and Quality Assurance. 414-415.
  • Show author(s) (1999). Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clinical Chemistry. 189-198.
  • Show author(s) (1999). Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clinical Chemistry. 189-198.
  • Show author(s) (1999). Circadian variations in human peripheral blood on days with and witout bone marrow sampling and relation to bone marroe cell proliferation. Biological rhythm research. 29-53.
  • Show author(s) (1999). Circadian variation in human peripheral blood on days with and without bone marrow sampling and relation to bone marrow proliferation. Biological rhythm research. 29-53.
  • Show author(s) (1999). Circadian Variations in Human Peripheral Blood on Days With and Without Bone Marrow Sampling and Relation to Bone Marrow Cell Proliferation. Biological rhythm research. 29-53.
  • Show author(s) (1999). Bruk og tolking av serum-kalsiumanalyse. Tidsskrift for Den norske legeforening. 3299.
  • Show author(s) (1998). Resultater fra NOKLUS' utsendelser 1993-97. Tidsskrift for Den norske legeforening. 1196-1200.
  • Show author(s) (1997). Use and usefulnes of laboratory handbooks. Scandinavian Journal of Clinical and Laboratory Investigation. 647-654.
  • Show author(s) (1997). Use and usefulnes of laboratory handbooks. Scandinavian Journal of Clinical and Laboratory Investigation. 647-654.
  • Show author(s) (1997). Use and usefullness of laboratory handbooks. Scandinavian Journal of Clinical and Laboratory Investigation. 647-654.
  • Show author(s) (1997). Systematic reviews of diagnostic tests - a new challenge for laboratory medicine. Scandinavian Journal of Clinical and Laboratory Investigation. 369-372.
  • Show author(s) (1997). Systematic reviews of diagnostic tests - a new challenge for laboratory medicine. Scandinavian Journal of Clinical and Laboratory Investigation. 369-372.
  • Show author(s) (1997). Systematic reviewing in laboratory medicine. JIFCC. 154-155.
  • Show author(s) (1997). Systematic review of diagnostic tests. Nordic newsletter on evidence-based health care. 5.
  • Show author(s) (1997). Systematic review of diagnostic tests. Nordic newsletter on evidence-based health care. 5-5.
  • Show author(s) (1997). SKUP - Skandinavisk samarbeid om utprøving av laboratorieutstyr for primærhelsetjenesten. Klinisk Biokemi i Norden. 49-52.
  • Show author(s) (1997). SKUP - Skandinavisk samarbeid om utprøving av laboratorieutstyr for primærhelsetjenesten. Klinisk Biokemi i Norden. 49-52.
  • Show author(s) (1997). Etablering av referanseverdier. Bioingeniøren. 5-7.
  • Show author(s) (1997). Etablering av referanseverdier. Bioingeniøren. 5-7.
  • Show author(s) (1996). Erythropoietic, protoporphyria: two populations of reticulocytes, with and without protoporphyrin. European Journal of Clinical Investigation. 270-8.
  • Show author(s) (1996). Analysekvalitet av hemoglobin og glukose i allmennpraksis. Tidsskrift for Den norske legeforening. 25-9.
  • Show author(s) (1995). Circadian phase relationships between peripheral blood variables and bone marrow proliferative activity in clinical health. In Vivo. 379-390.
  • Show author(s) (1995). Circadian phase relationships between peripheral blood variables and bone marrow proliferative activity in clinical health. In Vivo. 379-390.
  • Show author(s) (1995). Circadian phase relationship between peripheral blood variables and bone marrow proliferative activity in clinical health. In Vivo. 379-89.
Academic lecture
  • Show author(s) (2017). Type 2 diabetes in General Practice in Norway 2005-2014: Moderate improvements in risk Control but still major gaps in complication screening.
  • Show author(s) (2007). Control of patients' glucometers and SMBG technique in community pharmacies.
  • Show author(s) (2006). How to deal with qualitative tests? Principles.
  • Show author(s) (2004). Hvordan bruker legene urinstrimmelen til diagnostikk av UVI?
Abstract
  • Show author(s) (2014). POC testing instruments for diagnosing and monitoring diabetes in clinical settings. Biochemia Medica. S39-S40.
  • Show author(s) (2013). Searching for pharmacological chaperones aiding to stabilize hydroxymethylbilane synthase. The FEBS Journal. 298-298.
  • Show author(s) (2011). Psychosocial aspects of predictive genetic testing for acute intermittent porphyria in minors. British Journal of Dermatology. 1133-1134.
  • Show author(s) (2011). POST-ANALYTICAL EXTERNAL QUALITY ASSESSMENT - A WAY TO ASSESS TEST REQUESTING AND INTERPRETATION. Clinical Chemistry and Laboratory Medicine. S111-S111.
  • Show author(s) (2011). Optimizing porphyria diagnostics with emphasis on pre-analytical, analytical and postanalytical aspects S. Sandberg on behalf of EPNET. British Journal of Dermatology. 1129-1129.
  • Show author(s) (2010). Characterization of the molecular basis of acute intermittent porphyria. The FEBS Journal. 76-76.
  • Show author(s) (2010). CHARACTERIZATION OF THE MOLECULAR BASIS OF ACUTE INTERMITTENT PORPHYRIA. The Journal of Inherited Metabolic Disease (JIMD). S177-S177.
  • Show author(s) (2005). External quality assessments of whole blood prothrombin time: Comparison of two methods. Clinica Chimica Acta.
  • Show author(s) (2005). Can we interpret laboratory results correctly? Clinica Chimica Acta.
  • Show author(s) (2005). Between lot variation in external quality assessment of glucose: Clinical importance and effect on the evaluation of participants' performance. Clinica Chimica Acta.
Academic literature review
  • Show author(s) (2022). Critical review and meta-analysis of biological variation estimates for tumor markers. Clinical Chemistry and Laboratory Medicine. 494-504.
  • Show author(s) (2021). The European Biological Variation Study (EuBIVAS): A summary report. Clinical Chemistry and Laboratory Medicine. 1-13.
  • Show author(s) (2021). Setting analytical performance specifications using HbA1c as a model measurand. Clinica Chimica Acta. 407-414.
  • Show author(s) (2021). Biological variation of cardiac troponins in health and disease: A systematic review and meta-analysis. Clinical Chemistry. 256-264.
  • Show author(s) (2021). Acute intermittent porphyria: An overview of therapy developments and future perspectives focusing on stabilisation of HMBS and proteostasis regulators. International Journal of Molecular Sciences. 25 pages.
  • Show author(s) (2020). Critical appraisal and meta-analysis of biological variation estimates for kidney related analytes. Clinical Chemistry and Laboratory Medicine. 1-10.
  • Show author(s) (2019). Systematic review of the biological variation data for diabetes related analytes. Clinica Chimica Acta. 61-67.
  • Show author(s) (2019). Systematic review and meta-analysis of within-subject and between-subject biological variation estimates of 20 haematological parameters. Clinical Chemistry and Laboratory Medicine. 25-32.
  • Show author(s) (2019). Biological variation data for lipid cardiovascular risk assessment biomarkers. A systematic review applying the biological variation data critical appraisal checklist (BIVAC). Clinica Chimica Acta. 467-475.
  • Show author(s) (2017). Essential aspects of external quality assurance for point-of-care testing. Biochemia Medica. 81-85.
  • Show author(s) (2017). Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference. Clinical Chemistry and Laboratory Medicine. 189-194.
  • Show author(s) (2014). How to conduct External Quality Assessment Schemes for the pre-analytical phase? Biochemia Medica. 114-122.
  • Show author(s) (2013). Glucose meters - fit for clinical purpose. Clinical Chemistry and Laboratory Medicine. 943-952.
  • Show author(s) (2012). Self-monitoring of blood glucose in patients with diabetes who do not use insulinuare guidelines evidence-based? Diabetic Medicine. 1226-1236.
  • Show author(s) (2010). Self-monitoring of blood glucose with a focus on analytical quality: an overview. Clinical Chemistry and Laboratory Medicine. 963-972.
  • Show author(s) (2009). Evaluation of prescription and interpretation of microalbuminuria by general practitioners. Annales de Biologie Clinique. 47-53.
  • Show author(s) (2009). Current Issues in Measurement and Reporting of Urinary Albumin Excretion. Clinical Chemistry. 24-38.

More information in national current research information system (CRIStin)